Repolarization dispersion in patients with systemic sclerosis.


Journal

European journal of rheumatology
ISSN: 2147-9720
Titre abrégé: Eur J Rheumatol
Pays: Turkey
ID NLM: 101656068

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 30 12 2020
medline: 30 12 2020
entrez: 29 12 2020
Statut: ppublish

Résumé

Systemic sclerosis (SSc) is associated with increased cardiac morbidity and mortality. Whether some electrocardiographic markers of arrhythmias predispose to early cardiogenic death in SSc remains controversial. This study evaluated the occurrence of previously reported as well as unstudied markers of repolarization in patients with SSc and assessed their prognostic implications. A total of 21 patients with SSc and 31 unaffected controls were included in this prospective study. Electrocardiograms were conducted under strict standards. Repolarization and dispersion parameters and markers of late ventricular potentials were determined using designated computer software. Results of multiple beats were averaged. There were no significant differences between the SSc and control groups in average QT intervals, average corrected QT intervals, average QT interval dispersion (QTd), average QT corrected dispersion (QTcd), and QT dispersion ratio. However, average QT apex dispersion, average JT dispersion, average JT corrected dispersion, and Tpeak-Tend corrected were significantly higher in patients with SSc than in controls. Late ventricular potentials were not found in patients with SSc or in controls. Increased QTd and QTcd were recorded in 1 patient who experienced ventricular arrhythmia before inclusion in the study. None of the remaining patients with SSc or the controls developed arrhythmia during the 9-year follow-up. Abnormal repolarization parameters may be observed in patients with SSc. However, their prognostic significance with regard to increased risk for repolarization-associated ventricular arrhythmias and increased cardiac death could not be determined in this study. Our findings endorse additional studies on this matter.

Identifiants

pubmed: 33372887
pii: eurjrheum.2020.19215
doi: 10.5152/eurjrheum.2020.19215
pmc: PMC9770413
doi:

Types de publication

Journal Article

Langues

eng

Pagination

144-149

Références

Rev Port Cardiol (Engl Ed). 2019 Apr;38(4):299-303
pubmed: 31203919
J Electrocardiol. 2001 Apr;34(2):119-25
pubmed: 11320459
ISRN Cardiol. 2012;2012:258769
pubmed: 22957271
Semin Arthritis Rheum. 2014 Dec;44(3):338-44
pubmed: 25128430
Front Physiol. 2016 Sep 21;7:422
pubmed: 27708590
Rheumatology (Oxford). 2001 Oct;40(10):1102-5
pubmed: 11600738
Am Heart J. 1993 Jan;125(1):194-203
pubmed: 8417518
Rheumatology (Oxford). 2006 Nov;45(11):1395-8
pubmed: 16606654
J Rheumatol. 2002 Jul;29(7):1388-92
pubmed: 12136893
Hypertension. 1996 Jul;28(1):16-21
pubmed: 8675257
Ann Rheum Dis. 2010 Oct;69(10):1809-15
pubmed: 20551155
Cardiol J. 2016;23(3):242-9
pubmed: 27173681
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v16-7
pubmed: 18784129
Int J Cardiol. 1996 Feb;53(2):171-7
pubmed: 8682603
Clin Rheumatol. 2012 Jul;31(7):1093-6
pubmed: 22526475
Best Pract Res Clin Rheumatol. 2018 Aug;32(4):541-549
pubmed: 31174823
Int J Cardiol. 2015 Mar 1;182:20-2
pubmed: 25576711
Int J Cardiol. 2017 Jul 15;239:34
pubmed: 28560979
Psychopharmacology (Berl). 2017 Oct;234(20):3075-3081
pubmed: 28770276
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
J Clin Med Res. 2019 Jul;11(7):524-531
pubmed: 31236172
Int J Cardiol. 1996 Dec 6;57(2):151-60
pubmed: 9013267
J Intern Med. 1998 Feb;243(2):127-32
pubmed: 9566641
Int J Cardiol. 2017 Jul 15;239:33
pubmed: 28560978
Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4797-4803
pubmed: 29164584
Curr Rheumatol Rep. 2019 Jul 15;21(9):44
pubmed: 31304568
Arch Rheumatol. 2016 Jan 28;31(2):139-144
pubmed: 29900933
Circulation. 1991 Apr;83(4):1481-8
pubmed: 2013173
J Huazhong Univ Sci Technolog Med Sci. 2007 Oct;27(5):516-9
pubmed: 18060624
J Rheumatol. 1997 Dec;24(12):2358-63
pubmed: 9415642
Ann Ital Med Int. 1994 Jul-Sep;9(3):141-5
pubmed: 7946889
Heart Vessels. 2010 May;25(3):223-8
pubmed: 20512450

Auteurs

Udi Nussinovitch (U)

Department of Cardiology, Meir Medical Center, Kfar Saba, Israel;Applicative Cardiovascular Research Center (ACRC), Meir Medical Center, Kfar Saba, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Gil Beeri (G)

Department of Cardiology, Meir Medical Center, Kfar Saba, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Shiri Rubin (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Merav Lidar (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;Unit of Rheumatology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Yair Levi (Y)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;Department of Medicine E, Meir Medical Center, Kfar Saba, Israel.

Avi Livneh (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;Unit of Rheumatology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Department of Medicine and the Heller Institute of Medical Research, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Classifications MeSH